Human Genome falls; Array rallies By: MarketWatch April 20, 2010 at 10:45 AM EDT Shares of Human Genome Sciences fell in early trading Tuesday, pushed down by the release of mixed Phase III data for its eagerly-anticipated lupus drug Benlysta. Read More >> Related Stocks: Array Technologies Inc Gsk Plc ADR Johnson & Johnson Novartis Ag ADR